Background and Purpose. For patients with cystic fibrosis, chest physiotherapy is crucial for evacuating airway secretions. Because chest physiotherapy increases energy expenditure, fatigue and dyspnoea, non-invasive ventilation (NIV) could be beneficial for severely ill patients during airway clearance. The aim of the study is to evaluate and compare the effects between NIV and positive expiratory pressure (PEP) on airway clearance. Methods. Prospective, randomized trial compares PEP to NIV. Thirty-two subjects, mean age 31 years, mean forced expiratory volume in 1 second 47% (±14) and mean forced vital capacity 69% (±13), completed a 3-month randomized trial comparing NIV with standard PEP treatment as airway clearance technique. Lung functions testing, 6-minute walk test, blood gases, sputum culture and inflammatory parameters were measured before and after the treatment period. Results. There was a significant reduction in lung clearance index (LCI) following NIV compared with PEP (p = 0.01). LCI is performed within the lung function testing. Discussion. Non-invasive ventilation was shown to be a good alternative to PEP in chest physiotherapy for patients with cystic fibrosis who are severely ill.
Introduction
Cystic fibrosis (CF) is the most common lifeshortening autosomal recessive inherited disease affecting Caucasian people (Dodge and Lewis, 2005) . The two main clinical characteristics of CF are progressive pulmonary disease and pancreatic insufficiency (Matsui et al., 1998) .
Promoting airway clearance using respiratory physiotherapy remains a mainstream of treatment (Pisi and Chetta, 2009) . Respiratory physiotherapy needs to be carried out twice a day. Most patients with CF use positive expiratory pressure (PEP) during their physiotherapy treatment. PEP therapy is a form of breathing therapy that adds resistance to the exhalation. The volume of air increases in the lungs; more alveolar units are kept open. The sputum is evacuated with greater ease as well (Elkins et al., 2006) .
Patients could also use non-invasive ventilation (NIV) (Haworth et al., 1999) as their physiotherapy treatment, which has been shown to be effective during lung exacerbation (Holland et al., 2003) . NIV is the name for all types of ventilation that are non-invasive like bilevel positive airway pressure (PAP, two levels of pressure) and continuous positive airway pressure (one level of pressure). The use of NIV offers the patient an opportunity to increase their functional respiratory capacity with greater ease than the use of PEP mask. This happens because the patient is helped by the NIV device to reduce the work of breathing. The combination of inspiratory assistance with expiratory PAP has been argued to reduce the work of breathing and to alleviate respiratory distress (Stock et al., 1984) . For very ill patients who are more likely to become tired, this treatment would be a good alternative, which could also improve their quality of life (Ali and Kabir, 2007) .
During NIV treatment, the patient maintains a constant preset PAP with the goal of decreasing their inspiratory work (Granton and Kesten, 1998; Fauroux et al., 1999) . Positive pressure ventilation can be performed in the form of inspiratory pressure support that delivers a variable volume according to a preset inspiratory pressure (Moran et al., 2009) .
Non-invasive ventilation assists in breathing without the placement of any artificial airways. It also reduces respiratory rate, increases tidal volume, decreases dyspnoea, reduces transdiaphragmatic pressures, reduces the work of breathing and improves oxygenation with a reduction in hypercapnia. Ventilatory support can be achieved through a variety of interfaces (face, nasal-mouth, nasal piece or helmet mask) (Moran et al., 2013) .
To date, no studies have evaluated the use of NIV with the goal of increasing functional respiratory capacity during airway clearance in adult patients with CF. Most of the studies use NIV as means to rest the inspiratory muscle during airway clearance or during the night in order to treat hypercapnia (Moran et al., 2013) .
The aim of the study is to evaluate and compare the effects between NIV and PEP during airway clearance regarding lung function, oxygenation, gas exchange and physical performance in adults with CF.
Methods

Study design
It consisted of a prospective randomized study with a control group (no double-blind) formed by subjects with CF who were under NIV treatment (study group) and those under PEP treatment (control group). All measurements were carried out by an independent and blinded person. The period of the study was 3 months.
Subjects
Out of the 45 subjects who met the inclusion criteria, 32 accepted to participate in the study. The other 13 subjects declined to participate because they lived too far away from the hospital. Their lung function was not statistically different to the enrolled subjects. Inclusion criteria are as follows: subjects with CF at Stockholm CF centre, >18 years of age and forced expiratory volume in one second (FEV 1 ) between 20% and 69% of predicted value. Exclusion criteria are as follows: the presence of a symptomatic upper airway infection characterized by fever less than 1 month before entering the study, cognitive dysfunction, cardiorespiratory instability, infection with Burkholderia cepacia complex, gastroesophageal reflux, history of pneumothorax or massive haemoptysis.
The physiotherapist researcher described the study to the subjects who fulfilled the inclusion criteria, asking if they wanted to participate in the study.
After having been informed in written form and verbally about the study at their monthly visit with the physiotherapist (not the physiotherapy researcher) and consented to participate, the subjects were randomized by choosing an opaque envelope. Then they were assigned to one of the two groups: (1) NIV treatment as bilevel PAP or (2) PEP treatment (PEP-mask) group (standard treatment), 16 subjects in each group.
Materials
Measurements
Lung function tests included whole-body plethysmography (Sendormedics, Vmax Encore 22, USA).
Static and dynamic spirometries were recorded as well, diffusing capacity of the lung for carbon monoxide, lung clearance index (LCI) obtained by nitrogen (N2) and multiple breath washouts. The tests were performed according to American Thoracic Society guidelines (three acceptable trials per subject) and were recorded as percent of predictive values (Society, 1995) . The technicians of the pulmonary laboratory were blinded to the physiotherapy treatment of the subjects.
Sputum cultures, blood samples for measuring arterialized capillary blood gases and for inflammatory parameters (erythrocyte sedimentation rate, C-reactive protein and plasma viscosity) were taken once a month and analysed at the central laboratory of Karolinska University Hospital.
Before each physiotherapy session, research nurses blinded to the treatment of the subjects measured and recorded the following: respiratory rate, heart rate and oxygen saturation using a pulse oximeter and finger probe (Onyx vantage, Nonin, USA). Body mass index was recorded as well.
A 6-minute walk test was performed according to the American Thoracic Society (Laboratories ATSCoPSfCPF, 2002) . Oxygen saturation, Borg Scale of rate perceived exertion and Modified Borg Scale of dyspnea, heart rate (before and after the test) and metres were recorded by the physiotherapist (Borg, 1982; Kendrick et al., 2000) .
All measurements (lung function test, walk test, sputum samples and blood samples) were taken before the physiotherapy session.
Procedure
The study protocol is shown in Table 1 .
The following tests were performed before and after the intervention: lung function test, 6-minute walk test, sputum samples, inflammatory markers, blood gases, pulse oximetry and respiratory rate.
Respiratory Physiotherapy
Study group (randomized to NIV as bilevel PAP): Subjects performed their daily physiotherapy treatment with the help of bilevel PAP. Once a month, they met the physiotherapist and the doctor at the hospital.
Control group: The control group went through the same protocol as above but instead of using NIV they performed their treatment as usual with the PEP mask.
The daily physiotherapy treatment in both groups consisted of two sessions lasting 60 minutes twice a day for 3 months. It involved the following:
• Inhalation of the following substances: bronchodilators (dry powder inhaler) and hypertonic saline 7% (for about 10 minutes). This is routine for all CF subjects at Stockholm CF Center and is standardized with respect to dosage for each subject.
• Autogenic drainage (AD) was performed during inhalation of hypertonic saline for about 15 minutes. The aim in AD is to reach the highest possible airflow in different generations of bronchi by controlled breathing in a three-phase breathing exercise. The aim was to (a) unstick the peripheral mucus by (Schoni, 1989) .
• Allocation (the specific intervention for the two groups respectively):
• NIV was administrated with a bilevel PAP device (Vivo 40, Breas, Sweden). Inspiratory and expiratory pressure settings were determined at an acclimatation session. A minimum expiratory pressure of 10 cm H20 and inspiratory pressure of 20 cm H20 were given. The patient interface consisted of a face mask (Laerdahl Mask, Sweden) and a whisper (Whisper Swivel, Respironics, USA) between the mask and the NIV device. During the NIV session, the subject breathed for about 2 minutes during each cycle (see succeeding text).
• During PEP-control group-session, 10 breaths were performed. The subject breathed through a face mask Astra-Tech Astrazeneca, Södertälje, Sweden with a valve and an expiratory resistor. The diameter of the resistor was determined for each patient to give a steady PEP of 10-20 cm H20.
• Huffing (forced expiration technique): a forced expiration from mild to low volume, with the glottis open in order to evacuate secretions.
• Repetition of this cycle (inhalation, AD, PEP/NIV, huffing) during 1 hour.
One single physiotherapist supervised and conducted all the monthly treatment sessions. Telephone calls once a week to ensure maximum compliance were made by the same physiotherapist. Compliance was ascertained by weekly telephone calls in which the physiotherapist asked how the treatment was going and if there were any complications and if it was necessary to change anything in the treatment.
Statistics
The FEV 1 of the population was normally distributed. ANOVA General lineal model (GLM) was used to compare within group and to compare between groups. Post hoc contrast was used because the interaction between NIV and LCI was significant, p = 0.02. Power was calculated for FEV 1 in order to detect a 5% difference between pre-intervention and postintervention.
Calculations were made with statistics software (Statistica 7.0 Stat soft 2004; USA). Probability values p < 0.05 were considered significant.
Results
Thirty-two subjects, with a mean age of 31 years and a standard deviation of 10, fulfilled the selection criteria, accepted to participate and were randomly assigned treatment. All subjects completed the study protocol. Patient characteristics are shown in Table 2 . All subjects inhaled bronchodilators. Two subjects inhaled Dornase Alfa. Inspiratory pressure delivered during bilevel PAP ranged from 25 to 32 cm H20 and expiratory pressure from 12 to 14 cm H20. Both ranges were comfortable for the subjects.
Baseline FEV 1 varied between the subjects ranging from 22% to 69% of predicted value, no difference between groups at baseline, but bilevel PAP group had lower FEV 1 values (p = 0.07). Altogether, 19 subjects (13 NIV and 6 PEP) had FEV1 ≤50% predicted (range 22-50). Nine subjects had FEV 1 <35% (six NIV and three PEP) ( Table 3) .
There was a significant decrease in LCI following bilevel PAP treatment compared with the control group (p = 0.01, Table 3 and Figure 1 ). FEV 1 and FVC did not change significantly following either treatment (p = 0.52, p = 0.25, Table 4 ).
There were no differences between standard treatment and bilevel PAP in mean 6-minute walk test. Partial pressure of carbon dioxide did not change significantly following either treatment (p = 0.08, Table 3 ) nor did SpO2 peripheral capillary oxygen saturation and respiratory rate (data not shown).
The inflammatory markers, blood gases and sputum samples analysed monthly did not show any significant difference compared with baseline data (data not shown), indicating that the subjects were in stable conditions during the study. Functional residual capacity did not change in both groups after the treatment (data not shown). 
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Discussion
The main finding in this study on adult subjects with CF is the significant decrease in LCI after chest physiotherapy with assisted NIV in comparison with PEP during a 3-month period. This has not been shown before.
Both groups maintained their lung function during the study period, which is in agreement with previous short-term studies of airway clearance techniques, for example, standard treatment with airway clearance breathing technique had no positive effect on lung function parameters (Braggion et al., 1995) . On the other hand, subjects could maintain their FEV 1 and FVC, even those with severe disease. There is no study evaluating long-term (e.g. greater than or equal to 3 months) NIV as airway clearance in CF (Moran et al., 2013) . Consequently, there is a need for longterm randomized controlled trials evaluating long-term effect of NIV as airway clearance in this patient group. Some studies, however, show the effects of long-term NIV in CF as a bridge to lung transplantation (Flight et al., 2012) and in chronic obstructive pulmonary disease hypercapnic subjects (De Backer et al., 2011) . In the present study, the treatment period was chosen in order to evaluate the long-term (12 weeks) effects of NIV treatment.
It is known that LCI measured by multiple breath washouts is a sensitive measure of ventilation inhomogeneity. FEV 1 in health and early in CF disease mostly reflects proximal airways; LCI is considered to reflect abnormalities of the smaller airways that are considered the site of early lung injury in CF. LCI will be increased in the presence of airway narrowing caused by either inflammation or mucus plugging. It has been described as being more sensitive than spirometry in the early stages of CF lung disease (Davies et al., 2008) .
Lung clearance index has been used as an outcome measure and could be an efficient alternative to detect changes in the small airways, mostly in those patients who get easily tired with the performing of the lung function test (Subbarao et al., 2013) . The improvement in LCI shown in this study could be due to the longterm effects of NIV in alveolar ventilation and in the prevention of airway closure during chest physiotherapy (Oberwaldner et al., 1986; Granton and Kesten, 1998) . The minimum clinically important treatment difference for the LCI is still unclear. LCI may be more sensitive to detect any changes in small airways.
It has been shown that NIV can be safely used to assist airway clearance during acute exacerbations in adults with CF, and these beneficial effects may be seen in those with severe bronchial obstruction and reduced inspiratory muscle strength (Holland et al., 2003) . No adverse effects were observed during the use of NIV in our study.
All patients performed a 6-minute walk test. Even subjects with severe lung disease, for example, an FEV 1 below 35% of predicted value, did perform a good 6-minute walk test (more than 500 m) (Troosters et al., 2002) . Dennersten et al. have shown that subjects with CF can preserve peak working capacity, even if their lungs function is substantially impaired (Dennersten et al., 2009) . Although 6-minute walk test is a sub-maximal test, it is easy to perform. The standard procedure is a cycle ergometer test. The 6-minute walk test, however, could be useful for the most severely ill patients because it can easily be repeated (Ruf and Hebestreit, 2009 ). One single physiotherapist performed the physiotherapy treatment and followed up the subjects during the study once a week by phone call and monthly with physiotherapy treatment at the hospital. This was performed in order to have a good compliance as possible and to be sure that the subjects received the same instructions during chest physiotherapy sessions (Bernard and Cohen, 2004) .
The lung function test as well as the blood samples were performed by a blinded assistant. It is known that clinical trials with non-blinded outcome assessors have high observer bias (Hrobjartsson et al., 2013) .
All methods were standardized for CF patients, and they are part of the annual check-up.
Statistic analysis was powered for 80% in order to have two groups with 16 patients. This was powered for FEV 1 and not for any other parameters. Thus, the number of patients in the study could have affected the results. No sub-group analyses could be made.
The ventilator mode used in the study as a bilevel PAP unloads diaphragm, and it is used more frequently nowadays in different kinds of respiratory diseases because it is more comfortable than continuous positive airway pressure when high pressure is used (Aboussouan and Ricaurte, 2010) . Bilevel PAP modality provides high flow and is one of the most comfortable NIV device when high pressures are used; it provides the possibility of giving two levels of respiratory support. PEP maintains the airways in an open 'state', improves alveolar gas exchange, improves oxygenation and increases lung volume (Holland et al., 2003) .
Expiratory pressure setting in this study was kept at 12-14 cm H2O in order to have PEP effects during expiration. Inspiratory pressure were set to achieve the maximal level of pressure support associated with patient comfort and was ranged between 25 and 32 cm H2O. The inspiratory pressure was as high as subjects tolerated in order to increase temporarily subject's functional residual capacity and tidal volume. There are to our knowledge no other studies using high inspiratory pressure in CF as non-invasive ventilation.
Bilevel PAP has many advantages such as the following: decreases the work of breathing, increases functional residual capacity, improves gas exchange and improves general pulmonary function much easier than PEP because the subject is helped by the machine.
Positive expiratory pressure is a flow-dependent device. The pressure during the manoeuvres could be different under the procedure. But during NIV, the subjects breathe and receive support as inspiratory and expiratory pressures during the breathing cycle. The pressure is settled prior to starting NIV treatment. NIV is not flow dependent (Christensen et al., 1995) (British Thoracic Society Standards Of Care, C, 2002) .
Limitations of study
The study was powered for the detection of a 5% difference in FEV 1 . Thus, the study population might have been too small to detect significances regarding the other included parameters.
A further limitation of the study is that there was no control group consisting of patients with no assisted chest physiotherapy. For ethical reason, this was not possible. To measure hypercapnia, arterialized capillary blood gases were used and not arterial blood gases that is the gold standard. However, arterialized capillary blood gases show ventilation accurately (Zavorsky et al., 2007) .
Conclusion
Non-invasive ventilation was shown to be a good alternative to PEP in chest physiotherapy for patients with CF who were moderately to severely ill. NIV was as good, safe and effective as PEP. The results in lung function showed that LCI may be a more sensible tool to evaluate the effect of physiotherapy treatment than FEV 1 .
Long-term studies are needed to evaluate the effects of NIV in airways clearance and in mucus transport. Also the subjective experiences of the use of NIV should be evaluated.
Physiotherapy implications
The present study offers a new approach to physiotherapy treatment in CF. The patient's subjective experience of using NIV will be analysed in another qualitative study, but the present one shows a good physiological result.
